New Dynamics in Drug Pricing and Prescribing
Generics, market dynamics, and global demand are changing drug-spending patterns.
Janssen Announces Drug Donation Program for HIV Treatment-Experienced Children
Janssen's donation program will improve access to the company's approved HIV medicines for children and adolescents in sub-Saharan Africa.
Climate Change Drives New Opportunities in Outsourcing
Ongoing changes create new opportunities for CROs and CMOs.
Jimmy Carter and Pfizer Mark 15-Year Effort To Help End Blinding Trachoma
Former US President Jimmy Carter and Pfizer commemorate the 15th anniversary of the International Trachoma Initiative to end blinding trachoma by the year 2020.
BMS Grants Support Mental Health Needs of US Military Veterans
The Bristol-Myers Squibb Foundation is awarding 10 grants to fund programs for veterans and their families.
Pall Corporation to Acquire ATMI's LifeSciences Business for $185 million
Pall Corporation, a solutions provider in filtration, separation and purification, has signed a definitive agreement with ATMI to acquire ATMI's LifeSciences business unit for $185 million.
Cambrex Completes FDA Inspection
FDA completes an inspection of Cambrex's API manufacturing facility in Charles City, Iowa.
Metrics Appoints New Vice-President
Metrics appoints a new vice-president to manage and expand its fee-for-service operations.
Bridgepoint Development Capital Acquires Quotient Clinical
Bridgepoint Development Capital acquires Quotient for an undisclosed sum.
GDUFA Off to Good Start, But Storm Clouds on the Horizon
GDUFA is off to a good start from a facility inspection perspective, but there are storm clouds on the horizon.
Deficiencies Discovered in API Inspections Suggest Strategies for Improvement
PIC/S reviews deficiencies found during inspections of API manufacturing facilities, harmonizes GMP standards, and provides training for inspectors worldwide.
